These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8330471)

  • 21. Effects of cotinine on cigarette self-administration.
    Hatsukami D; Lexau B; Nelson D; Pentel PR; Sofuoglu M; Goldman A
    Psychopharmacology (Berl); 1998 Jul; 138(2):184-9. PubMed ID: 9718288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels.
    Hurt RD; Dale LC; Croghan GA; Croghan IT; Gomez-Dahl LC; Offord KP
    Mayo Clin Proc; 1998 Feb; 73(2):118-25. PubMed ID: 9472993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term nicotine substitution after application of a 16-hour nicotine patch in smoking cessation.
    Nørregaard J; Tønnesen P; Simonsen K; Säwe U
    Eur J Clin Pharmacol; 1992; 43(1):57-60. PubMed ID: 1505610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smoking reduction in smokers compliant to a smoking cessation trial with nicotine patch.
    Fornai E; Desideri M; Pistelli F; Carrozzi L; Puntoni R; Avino S; Gustavsson G; Säwe U; Viegi G; Giuntini C
    Monaldi Arch Chest Dis; 2001 Feb; 56(1):5-10. PubMed ID: 11407211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors and timing of adverse experiences during trandsdermal nicotine therapy.
    Gourlay SG; Forbes A; Marriner T; McNeil JJ
    Drug Saf; 1999 Jun; 20(6):545-55. PubMed ID: 10392670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-week outcomes.
    Kalman D; Kahler CW; Garvey AJ; Monti PM
    J Subst Abuse Treat; 2006 Apr; 30(3):213-7. PubMed ID: 16616165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptoms of nicotine toxicity in subjects achieving high cotinine levels during nicotine replacement therapy.
    Tonstad S; Gustavsson G; Kruse E; Walmsley JM; Westin Å
    Nicotine Tob Res; 2014 Sep; 16(9):1266-71. PubMed ID: 24852574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of transdermal nicotine delivery on measures of acute nicotine withdrawal.
    Pickworth WB; Fant RV; Butschky MF; Henningfield JE
    J Pharmacol Exp Ther; 1996 Nov; 279(2):450-6. PubMed ID: 8930145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
    Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
    Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
    Dalack GW; Becks L; Hill E; Pomerleau OF; Meador-Woodruff JH
    Neuropsychopharmacology; 1999 Aug; 21(2):195-202. PubMed ID: 10432467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment.
    Gourlay SG; Benowitz NL; Forbes A; McNeil JJ
    Eur J Clin Pharmacol; 1997; 51(5):407-14. PubMed ID: 9049583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) and half-hourly cigarette smoking.
    Gupta SK; Hwang SS; Causey D; Rolf CN; Gorsline J
    J Clin Pharmacol; 1995 Oct; 35(10):985-9. PubMed ID: 8568016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of 24-hr nicotine replacement on sleep and daytime activity during smoking cessation.
    Wolter TD; Hauri PJ; Schroeder DR; Wisbey JA; Croghan IT; Offord KP; Dale LC; Hurt RD
    Prev Med; 1996; 25(5):601-10. PubMed ID: 8888329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.
    Lerman C; Tyndale R; Patterson F; Wileyto EP; Shields PG; Pinto A; Benowitz N
    Clin Pharmacol Ther; 2006 Jun; 79(6):600-8. PubMed ID: 16765148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of nicotine patch or nasal spray on nicotine and cotinine concentrations in pregnant smokers.
    Oncken C; Campbell W; Chan G; Hatsukami D; Kranzler HR
    J Matern Fetal Neonatal Med; 2009 Sep; 22(9):751-8. PubMed ID: 19526424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal nicotine replacement and smoking cessation.
    McKenna JP; Cox JL
    Am Fam Physician; 1992 Jun; 45(6):2595-602. PubMed ID: 1595510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia.
    Tidey JW; O'Neill SC; Higgins ST
    Exp Clin Psychopharmacol; 2002 Aug; 10(3):241-7. PubMed ID: 12233984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of effect of 5HT3 antagonist in mediating subjective and behavioral responses to cotinine.
    Hatsukami DK; Jensen J; Brauer LH; Mooney M; Schulte S; Sofuoglu M; Pentel PR
    Pharmacol Biochem Behav; 2003 Apr; 75(1):1-7. PubMed ID: 12759107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nicotine, cotinine, withdrawal, and craving patterns during smoking and nicotine nasal spray use: results from a pilot study with African American men.
    Mabry PL; Tooze JA; Moser RP; Augustson EM; Malcolm RJ; Benowitz NL
    Nicotine Tob Res; 2007 Jan; 9(1):65-82. PubMed ID: 17365738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nicotine replacement therapy for smoking cessation.
    Silagy C; Mant D; Fowler G; Lancaster T
    Cochrane Database Syst Rev; 2000; (2):CD000146. PubMed ID: 10796494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.